Introducing an Expanded Value Framework in Health Technology Assessment of Vaccines
Journal of Market Access & Health Policy · 28.04.2026 · 14 (2) · 24
DOI: 10.3390/jmahp14020024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Market Access & Health Policy, online erschienen am 28.04.2026. Verfasst von Farzaneh Eslami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Global Health, Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, 9713 GZ Groningen, The Net…. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Health Technology Assessment (HTA) frameworks increasingly recognize the broader value elements of vaccines; however, their adoption remains inconsistent across jurisdictions and often incomplete in practice. Many HTA processes continue to prioritize narrow clinical outcomes and direct costs, leading to the underrepresentation of the full preventive and long-term benefits of vaccination. Building on the ISPOR “Elements of Value” framework and recent evidence, this study adapts and expands existing models specifically for vaccines to enhance HTA applicability in both high-income and resource-limited settings. We introduce an updated vaccine value framework comprising 21 distinct value elements. Notably, the original model was expanded by introducing four entirely new value drivers: (1) real-world evidence; (2) control of antimicrobial resistance; (3) health system strengthening; and (4) environmental impact. Additionally, existing elements were refined, such as broadening “fear of contagion” to “peace of mind” and expanding “productivity” to capture education and leisure gains. We map these elements to potential data sources and methodological tools to facilitate their inclusion in HTA. This study offers an operational, holistic, and context-sensitive framework that reflects current advancements in assessment. By capturing the full spectrum of vaccine value, this framework aims to support more comprehensive, transparent, and equitable HTA decision-making for global immunization programs, while considering conceptual overlap between value elements to reduce the risk of double counting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Global Health, Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
- Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung 45363, Indonesia.
- Faculty of Public Health, Thai Nguyen University of Medicine and Pharmacy, Thai Nguyen 250000, Vietnam.
- Health-Ecore, 3704 HE Zeist, The Netherlands.
- Health-Ecore, 9728 JT Groningen, The Netherlands.
ORCID-Profile: Farzaneh Eslami, Thi Hao Pham, Cao Ba Khuong, Jurjen van der Schans
Zitieren
APA
Eslami, F., Pham, T. H., Kautsar, A. P., Khuong, C. B., Boersma, C., Toumi, M., van der Schans, J., & Postma, M. J. (2026). Introducing an Expanded Value Framework in Health Technology Assessment of Vaccines. Journal of Market Access & Health Policy, 14(2), 24. https://doi.org/10.3390/jmahp14020024
Vancouver
Eslami F, Pham TH, Kautsar AP, Khuong CB, Boersma C, Toumi M, et al. Introducing an Expanded Value Framework in Health Technology Assessment of Vaccines. Journal of Market Access & Health Policy. 2026;14(2):24. doi:10.3390/jmahp14020024
BibTeX
@article{Eslami2026,
author = {Eslami, Farzaneh and Pham, Thi Hao and Kautsar, Angga P and Khuong, Cao Ba and Boersma, Cornelis and Toumi, Mondher and van der Schans, Jurjen and Postma, Maarten J},
title = {Introducing an Expanded Value Framework in Health Technology Assessment of Vaccines},
journal = {Journal of Market Access & Health Policy},
year = {2026},
volume = {14},
number = {2},
pages = {24},
doi = {10.3390/jmahp14020024}
}
EUVIMED